From genome to drugs: new approaches in antimicrobial discovery

F Serral, FA Castello, EJ Sosa, AM Pardo… - Frontiers in …, 2021 - frontiersin.org
Decades of successful use of antibiotics is currently challenged by the emergence of
increasingly resistant bacterial strains. Novel drugs are urgently required but, in a scenario …

[HTML][HTML] Combining structure and genomics to understand antimicrobial resistance

T Tunstall, S Portelli, J Phelan, TG Clark… - Computational and …, 2020 - Elsevier
Antimicrobials against bacterial, viral and parasitic pathogens have transformed human and
animal health. Nevertheless, their widespread use (and misuse) has led to the emergence of …

Target-Pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens

EJ Sosa, G Burguener, E Lanzarotti… - Nucleic acids …, 2018 - academic.oup.com
Available genomic data for pathogens has created new opportunities for drug discovery and
development to fight them, including new resistant and multiresistant strains. In particular …

Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection

M Hakamata, H Takihara, T Iwamoto, A Tamaru… - Scientific reports, 2020 - nature.com
Mycobacterium tuberculosis (Mtb) strains of Beijing lineage have caused great concern
because of their rapid emergence of drug resistance and worldwide spread. DNA mutation …

An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets

PIP Ramos, D Fernandez Do Porto, E Lanzarotti… - Scientific reports, 2018 - nature.com
Klebsiella pneumoniae (Kp) is a globally disseminated opportunistic pathogen that can
cause life-threatening infections. It has been found as the culprit of many infection outbreaks …

From drugs to targets: Reverse engineering the virtual screening process on a proteomic scale

G Schottlender, JM Prieto, MC Palumbo… - Frontiers in Drug …, 2022 - frontiersin.org
Phenotypic screening is a powerful technique that allowed the discovery of antimicrobials to
fight infectious diseases considered deadly less than a century ago. In high throughput …

Core regulon of the global anaerobic regulator Anr targets central metabolism functions in Pseudomonas species

PM Tribelli, AM Lujan, A Pardo, JG Ibarra… - Scientific Reports, 2019 - nature.com
A comparative genome analysis of the global anaerobic regulator Anr regulon in five
species of Pseudomonas with different life style was performed. Expression of this regulator …

Integrating diverse layers of omic data to identify novel drug targets in Listeria monocytogenes

M Palumbo, E Sosa, F Castello… - Frontiers in Drug …, 2022 - frontiersin.org
Listeria monocytogenes (Lm) is a Gram-positive bacillus responsible for listeriosis in
humans. Listeriosis has become a major foodborne illness in recent years. This illness is …

Contribution and future of high-throughput transcriptomics in battling tuberculosis

A Martínez-Pérez, O Estévez… - Frontiers in …, 2022 - frontiersin.org
While Tuberculosis (TB) infection remains a serious challenge worldwide, big data and
“omic” approaches have greatly contributed to the understanding of the disease …

A multi-pronged computational pipeline for prioritizing drug target strategies for latent tuberculosis

U Banerjee, S Sankar, A Singh, N Chandra - Frontiers in chemistry, 2020 - frontiersin.org
Tuberculosis is one of the deadliest infectious diseases worldwide and the prevalence of
latent tuberculosis acts as a huge roadblock in the global effort to eradicate tuberculosis …